Infusion Service

Central Coast Neurosciences Research was established in 1996 and is co-headed by Associate Professor Denis Crimmins and Associate Professor Jonathan Sturm.

CCNR has been administering intravenous monoclonal antibody therapies since 2015.

The research team consists of:

  • Neurologists: A /Prof Denis Crimmins, A/Prof Jonathan Sturm,  Dr Yun Tae Hwang, Dr Anna Schutz, Dr Khaled Alanati
  • Neuropsychologist: Dr Natalie Lambert
  • Registered Nurse: Michelle Anderson

Currently the TGA approved intravenous treatments administered are:

  • Amyloid Targeted Therapies: Donanemab (Kisunla) and Lecanemab (Leqembi)
  • Migraine Prevention: Eptinezumab (Vyepti)

The infusion service is operated at two locations on the Central Coast, at Erina and Tumbi Umbi.

Referrals can be sent to Central Coast Neurosciences at either the Erina or Tumbi Umbi clinics.